Form 8-K - Current report:
SEC Accession No. 0001477932-25-002897
Filing Date
2025-04-22
Accepted
2025-04-22 17:16:09
Documents
18
Period of Report
2025-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vnrx_8k.htm   iXBRL 8-K 32284
2 SALES AGREEMENT vnrx_ex11.htm EX-1.1 223315
3 LEGAL OPINION OF STRADLING YOCCA CARLSON & RAUTH LLP vnrx_ex51.htm EX-5.1 10793
9 vnrx_ex51img1.jpg GRAPHIC 3415
  Complete submission text file 0001477932-25-002897.txt   454531

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20250422.xsd EX-101.SCH 5874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20250422_lab.xml EX-101.LAB 14667
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20250422_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20250422_pre.xml EX-101.PRE 9275
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20250422_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_8k_htm.xml XML 3905
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 25858568
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)